By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Population Genetics today announced the closing of a Series B financing round that brought in $5.7 million.

The funds will be used to complete validation of the company's technology, "setting the stage for a future major financing aimed at making that technology broadly available," the UK-based firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.